Global Small Molecule Targeted Cancer Therapy Market is Set to Grow Rapidly

Zion Market Research has published a new report titled “Small Molecule Targeted Cancer Therapy Market By Type (Small Molecule Drug Conjugates, Small Molecules (Small Molecule Cyclin-Dependent Kinase Inhibitor, Small Molecule Proteasome Inhibitor, Small Molecule Tyrosine Kinase Inhibitor), And Monoclonal Antibodies(Fully Human Antibody, Chimeric Monoclonal Antibody, Humanized Monoclonal Antibody)), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032”.

Targeted cancer therapy uses drugs to target specific cancer proteins, tissue environment and genes that assist in the growth and survival of cancer cells. Such proteins or genes are present in cells of the blood vessel or cancerous cells and they support cancer development and growth. Targeted therapy includes use of hormone therapies, inhibitors of signal transduction, inducers of apoptosis, angiogenesis inhibitors, modulators of gene expression, monoclonal antibodies, immunotherapies etc. Molecules used in small molecule targeted therapy are usually of ≤5000 Da and are administered orally. Because of their small size, these molecules can easily translocate via the plasma membrane and interact with the cytoplasmic domain of intracellular signaling molecules and cell surface receptors.

Browse the full “Small Molecule Targeted Cancer Therapy Market By Type (Small Molecule Drug Conjugates, Small Molecules (Small Molecule Cyclin-Dependent Kinase Inhibitor, Small Molecule Proteasome Inhibitor, Small Molecule Tyrosine Kinase Inhibitor), And Monoclonal Antibodies(Fully Human Antibody, Chimeric Monoclonal Antibody, Humanized Monoclonal Antibody)), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032.” Report at https://www.zionmarketresearch.com/report/small-molecule-targeted-cancer-therapy-market

The global small molecule targeted cancer therapy market growth is fueled by factors such as increasing preference for cancer drugs or therapies with minimal side effects and adverse events, increasing prevalence of cancer and growing health awareness. Also, increasing adoption of targeted therapies over chemotherapy, increasing disposable income and health spending are factors supporting the market growth. However, stringent regulatory requirements, slower drug approval process, and high operational cost are factors that may impede the market growth in the coming years. Patent expiry of major drugs is anticipated to open new growth avenues over the forecast period for market players.

The global small molecule targeted cancer therapy market is segmented based on type, and region. Based on type, market is segmented into small molecule drug conjugates, small molecules and monoclonal antibodies. In 2023, small molecules type segment held major revenue share of global market due to lesser side effects and its effectiveness. Small molecules type segment is sub segmented into small molecule tyrosine kinase inhibitor, proteasome inhibitor and small molecule cyclin-dependent kinase inhibitor. Monoclonal antibodies segment is further split into humanized monoclonal antibody, chimeric monoclonal antibody and fully human antibody. Small molecule drug conjugates segment is projected to witness highest growth over the forecast period.

At regional level, North America held largest market share of global market in 2023. This is due to various factors such as increasing prevalence of cancer, increasing preference for therapies with minimal side effects, presence of advanced health facilities, favorable reimbursement policies, and increasing health spending. Europe was second leading regional market in 2018. Faster adoption of novel therapies and growing awareness about cancer and advanced therapies are key factors promoting market growth in this region. Asia Pacific region is estimated to exhibit fastest growth for small molecule targeted cancer therapy market in the coming years. Increasing cancer prevalence, large population base, growing demand for targeted therapy over chemotherapy, increasing healthcare spending and government initiatives to create awareness are important factors that support Asia Pacific small molecule targeted cancer therapy market growth. Latin America is anticipated to register moderate growth in the coming years. Middle East and Africa region is estimated to show slower growth over the forecast period.

Major players included in the report are Bayer HealthCare AG, Abbott Laboratories, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Cytokinetics Inc., OncoGenex Pharmaceuticals, Inc. and Hospira Inc. among others.

The report segment of global small molecule targeted cancer therapy market as follows:

Global Small Molecule Targeted Cancer Therapy Market: By Type

• Monoclonal Antibodies
  • Fully Human Antibody
  • Chimeric Monoclonal Antibody
  • Humanized Monoclonal Antibody
• Small Molecules
  • Small Molecule Cyclin-dependent Kinase Inhibitor
  • Small Molecule Proteasome Inhibitor
  • Small Molecule Tyrosine Kinase Inhibitor
• Small Molecule Drug Conjugates

Global Small Molecule Targeted Cancer Therapy Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com